
Layla D. Berry
Examiner (ID: 2498, Phone: (571)272-9572 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1609, 1693, 1623, 1673 |
| Total Applications | 1717 |
| Issued Applications | 1094 |
| Pending Applications | 107 |
| Abandoned Applications | 562 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18612454
[patent_doc_number] => 20230279186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => Hydrogels Based On Functionalized Polysaccharides
[patent_app_type] => utility
[patent_app_number] => 17/991608
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17991608
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/991608 | Hydrogels based on functionalized polysaccharides | Nov 20, 2022 | Issued |
Array
(
[id] => 18322594
[patent_doc_number] => 20230120722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => METHOD FOR DISSOLVING SCARS WITH DEXTRAN SULFATE
[patent_app_type] => utility
[patent_app_number] => 18/056301
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056301
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056301 | Method for dissolving scars with dextran sulfate | Nov 16, 2022 | Issued |
Array
(
[id] => 19265318
[patent_doc_number] => 20240209017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => STING MODULATOR COMPOUNDS, AND METHODS OF MAKING AND USING
[patent_app_type] => utility
[patent_app_number] => 18/052083
[patent_app_country] => US
[patent_app_date] => 2022-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052083
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/052083 | Sting modulator compounds, and methods of making and using | Nov 1, 2022 | Issued |
Array
(
[id] => 18709149
[patent_doc_number] => 20230331760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => ARYL GLUCOSIDE DERIVATIVE AND USE THEREOF IN DRUG
[patent_app_type] => utility
[patent_app_number] => 17/972982
[patent_app_country] => US
[patent_app_date] => 2022-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17972982
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/972982 | Aryl glucoside derivative and use thereof in drug | Oct 24, 2022 | Issued |
Array
(
[id] => 19396175
[patent_doc_number] => 12070504
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-08-27
[patent_title] => Compounds and methods for altering cyto-states of cells that express c-type lectin receptors
[patent_app_type] => utility
[patent_app_number] => 17/972041
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20447
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 676
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17972041
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/972041 | Compounds and methods for altering cyto-states of cells that express c-type lectin receptors | Oct 23, 2022 | Issued |
Array
(
[id] => 18837707
[patent_doc_number] => 11845770
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Ascaroside derivatives and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/971194
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 32
[patent_no_of_words] => 29345
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17971194
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/971194 | Ascaroside derivatives and methods of use | Oct 20, 2022 | Issued |
Array
(
[id] => 19637423
[patent_doc_number] => 12168019
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-17
[patent_title] => 8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expression
[patent_app_type] => utility
[patent_app_number] => 17/970999
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19885
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17970999
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/970999 | 8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expression | Oct 20, 2022 | Issued |
Array
(
[id] => 18229862
[patent_doc_number] => 20230068856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/970080
[patent_app_country] => US
[patent_app_date] => 2022-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17970080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/970080 | Hydroxypropyl beta-cyclodextrin compositions and methods | Oct 19, 2022 | Issued |
Array
(
[id] => 18181251
[patent_doc_number] => 20230041980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => METHOD OF PROTECTING A RESPIRATORY TRACT OR A LUNG FROM DAMAGE, METHOD OF PROTECTING A LUNG FROM PRESSURE DAMAGE INDUCED BY A VENTILATOR, METHOD OF SUPPRESSING SPREAD OF INFECTION WITH VIRUSES OR BACTERIA THAT CAUSE PNEUMONIA IN PULMONARY BRONCHIAL EPITHELIAL CELLS OR ALVEOLAR EPITHELIAL CELLS, AND NASAL SPRAY
[patent_app_type] => utility
[patent_app_number] => 17/967775
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17967775
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/967775 | METHOD OF PROTECTING A RESPIRATORY TRACT OR A LUNG FROM DAMAGE, METHOD OF PROTECTING A LUNG FROM PRESSURE DAMAGE INDUCED BY A VENTILATOR, METHOD OF SUPPRESSING SPREAD OF INFECTION WITH VIRUSES OR BACTERIA THAT CAUSE PNEUMONIA IN PULMONARY BRONCHIAL EPITHELIAL CELLS OR ALVEOLAR EPITHELIAL CELLS, AND NASAL SPRAY | Oct 16, 2022 | Abandoned |
Array
(
[id] => 19121026
[patent_doc_number] => 11964996
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => 2-alkynylmannose derivative and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/956774
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16100
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 777
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17956774
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/956774 | 2-alkynylmannose derivative and application thereof | Sep 28, 2022 | Issued |
Array
(
[id] => 20171763
[patent_doc_number] => 12390483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Compounds and methods for treating neurological and cardiovascular conditions
[patent_app_type] => utility
[patent_app_number] => 17/934169
[patent_app_country] => US
[patent_app_date] => 2022-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 28
[patent_no_of_words] => 26295
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934169
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934169 | Compounds and methods for treating neurological and cardiovascular conditions | Sep 20, 2022 | Issued |
Array
(
[id] => 18161292
[patent_doc_number] => 20230027884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/946670
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946670 | Hydroxypropyl beta-cyclodextrin compositions and methods | Sep 15, 2022 | Issued |
Array
(
[id] => 18550880
[patent_doc_number] => 20230248880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => IMPLANTS FOR SCULPTING, AUGMENTING OR CORRECTING FACIAL FEATURES SUCH AS THE CHIN
[patent_app_type] => utility
[patent_app_number] => 17/943075
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943075
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/943075 | Implants for sculpting, augmenting or correcting facial features such as the chin | Sep 11, 2022 | Issued |
Array
(
[id] => 18166723
[patent_doc_number] => 20230033327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/896154
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17896154
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/896154 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | Aug 25, 2022 | Abandoned |
Array
(
[id] => 18478271
[patent_doc_number] => 11692001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Functionalized n-acetylgalactosamine analogs
[patent_app_type] => utility
[patent_app_number] => 17/822679
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18405
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822679
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822679 | Functionalized n-acetylgalactosamine analogs | Aug 25, 2022 | Issued |
Array
(
[id] => 18210298
[patent_doc_number] => 20230056560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => BINDERS AND ASSOCIATED PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/890823
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7639
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890823 | Binders and associated products | Aug 17, 2022 | Issued |
Array
(
[id] => 19667516
[patent_doc_number] => 12180244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => (Thio)nicotinamide ribofuranoside salts and compositions, methods of making, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/820816
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12440
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820816 | (Thio)nicotinamide ribofuranoside salts and compositions, methods of making, and uses thereof | Aug 17, 2022 | Issued |
Array
(
[id] => 18056378
[patent_doc_number] => 20220387464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => INOSITOL PHOSPHATE-CONTAINING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/888952
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888952
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/888952 | INOSITOL PHOSPHATE-CONTAINING COMPOSITION | Aug 15, 2022 | Abandoned |
Array
(
[id] => 18077350
[patent_doc_number] => 20220402962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => SYNTHESIS OF PHOSPHATE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/888312
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/888312 | Synthesis of phosphate derivatives | Aug 14, 2022 | Issued |
Array
(
[id] => 19325951
[patent_doc_number] => 12043616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Crystalline forms of nicotinamide riboside chloride
[patent_app_type] => utility
[patent_app_number] => 17/887060
[patent_app_country] => US
[patent_app_date] => 2022-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 6
[patent_no_of_words] => 12183
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17887060
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/887060 | Crystalline forms of nicotinamide riboside chloride | Aug 11, 2022 | Issued |